AAAAAA

   
Results: 1-11 |
Results: 11
Variability in repeated pattern ventricular arrhythmia: Application of a reentry model
Authors: Sapoznikov, D Luria, MH
Citation: D. Sapoznikov et Mh. Luria, Variability in repeated pattern ventricular arrhythmia: Application of a reentry model, J ELCARDIOL, 34(3), 2001, pp. 225-231
Inheritance of heart rate variability: the kibbutzim family study (vol 105, pg 654, 1999)
Authors: Sinnreich, R Friedlander, Y Luria, MH Sapoznikov, D Kark, JD
Citation: R. Sinnreich et al., Inheritance of heart rate variability: the kibbutzim family study (vol 105, pg 654, 1999), HUM GENET, 107(1), 2000, pp. 96-96
Pharmacodynamic effects of bezafibrate and niacin combination: Implications of the mode of administration
Authors: Lomnicky, Y Haimov, T Luria, MH Friedman, M Hoffman, A
Citation: Y. Lomnicky et al., Pharmacodynamic effects of bezafibrate and niacin combination: Implications of the mode of administration, J PHARM SCI, 89(8), 2000, pp. 1046-1053
Enhancing long-term ECG monitoring with graphic analysis of coupling intervals
Authors: Sapoznikov, D Luria, MH Gotsman, MS
Citation: D. Sapoznikov et al., Enhancing long-term ECG monitoring with graphic analysis of coupling intervals, J ELCARDIOL, 33(2), 2000, pp. 137-145
Heart rate variability during chronic hemodialysis and after renal transplantation: Studies in patients without and with systemic amyloidosis
Authors: Rubinger, D Sapoznikov, D Pollak, A Popovtzer, MM Luria, MH
Citation: D. Rubinger et al., Heart rate variability during chronic hemodialysis and after renal transplantation: Studies in patients without and with systemic amyloidosis, J AM S NEPH, 10(9), 1999, pp. 1972-1981
Improved lipid lowering activity of bezafibrate following continuous gastrointestinal administration: Pharmacodynamic rationale for sustained releasepreparation of the drug
Authors: Hoffman, A Lomnicky, Y Luria, MH Gilhar, D Friedman, M
Citation: A. Hoffman et al., Improved lipid lowering activity of bezafibrate following continuous gastrointestinal administration: Pharmacodynamic rationale for sustained releasepreparation of the drug, PHARM RES, 16(7), 1999, pp. 1093-1097
Inheritance of heart rate variability: the kibbutzim family study
Authors: Sinnreich, R Friedlander, Y Luria, MH Sapoznikov, D Kark, JD
Citation: R. Sinnreich et al., Inheritance of heart rate variability: the kibbutzim family study, HUM GENET, 105(6), 1999, pp. 654-661
Simulation of ventricular arrhythmias using a re-entry model algorithm
Authors: Sapoznikov, D Luria, MH Gotsman, MS
Citation: D. Sapoznikov et al., Simulation of ventricular arrhythmias using a re-entry model algorithm, COMPUT M PR, 60(1), 1999, pp. 45-54
Changes in sinus RR interval patterns preceding ventricular ectopic beats:assessment with rate enhancement and dynamic heart rate trends
Authors: Sapoznikov, D Luria, MH Gotsman, MS
Citation: D. Sapoznikov et al., Changes in sinus RR interval patterns preceding ventricular ectopic beats:assessment with rate enhancement and dynamic heart rate trends, INT J CARD, 69(2), 1999, pp. 217-224
The effect of the mode of administration on the hypolipidaemic activity ofniacin: Continuous gastrointestinal administration of low-dose niacin improves lipid-lowering efficacy in experimentally-induced hyperlipidaemic rats
Authors: Lomnicky, Y Friedman, M Luria, MH Raz, I Hoffman, A
Citation: Y. Lomnicky et al., The effect of the mode of administration on the hypolipidaemic activity ofniacin: Continuous gastrointestinal administration of low-dose niacin improves lipid-lowering efficacy in experimentally-induced hyperlipidaemic rats, J PHARM PHA, 50(11), 1998, pp. 1233-1239
Heart rate variability as a marker of myocardial perfusion
Authors: Schechter, D Sapoznikov, D Luria, MH Mendelson, S Bocher, M Chisin, R
Citation: D. Schechter et al., Heart rate variability as a marker of myocardial perfusion, CARDIOLOGY, 90(4), 1998, pp. 239-243
Risultati: 1-11 |